CEP-26401 Uses, Dosage, Side Effects and more
CEP-26401 has been used in trials studying Cognitive Impairment.
| Attribute | Details |
|---|---|
| Trade Name | CEP-26401 |
| Generic | Irdabisant |
| Irdabisant Other Names | CEP-26401, Irdabisant |
| Type | |
| Formula | C18H23N3O2 |
| Weight | Average: 313.401 Monoisotopic: 313.179026993 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
Innovators Monograph
Search Medicines
